Do You Have Heavy Menstrual Bleeding Due to Uterine Fibroids?
Physicians’ Research Options is looking for women to participate in the LIBERTY 2 research study to evaluate whether an investigational medicine could reduce the amount of heavy menstrual bleeding due to uterine fibroids.
Call Us: (303) 985-9100
or fill out the form
to inquire about participating
Do You Have Heavy Menstrual Bleeding Due to Uterine Fibroids?
Physicians’ Research Options is looking for women to participate in the LIBERTY 2 research study to evaluate whether an investigational medicine could reduce the amount of heavy menstrual bleeding due to uterine fibroids.
Call Us: (303) 985-9100
or fill out the form
to inquire about participating
ABOUT THE STUDY
The purpose of the LIBERTY 2 research study is to help determine whether the investigational medicine being used in the trial is safe and effective for treating heavy menstrual bleeding associated with uterine fibroids.
Criteria:
The first step to find out if you are eligible for the LIBERTY 2 research study is to go through a screening process, so a physician or other research health care professionals can ensure you meet criteria for the study.
To qualify, participants in this study will be women who:
- Are 18 to 50 years of age
- Have monthly menstrual periods
- Experience heavy menstrual bleeding due to uterine fibroids
- Have days when their feminine products (pads, tampons, liners) become soaked and need to be changed more than 3 times a day
- Additional requirements apply
If you are eligible, you will receive study medicine and study-related care at no cost to you and may be compensated for time and transportation.
Frequently Asked Questions
Can you tell me more about the LIBERTY 2 research study?
- The LIBERTY 2 research study is a Phase 3 clinical trial.
- Clinical trials are usually conducted in three phases before the investigational medicine is considered for approval by the regulatory authority: a Phase 1 trial, which typically involves a small number of participants to determine a safe dose and preliminary safety, and Phase 2 and 3 trials, which involve a larger number of participants and test the effectiveness and safety of the investigational medicine(s).
- Successful completion of the LIBERTY Phase 3 trials and evaluation by the study sponsor of whether study results could support marketing approval is the last step before study results are submitted to the U.S. FDA for review and consideration of approval for treatment of heavy bleeding associated with uterine fibroids.
- You can see additional details about the LIBERTY 2 research study at https://clinicaltrials.gov/ct2/show/NCT03103087
Will I have to pay for anything to participate in the LIBERTY 2 research study?
- As part of the study, you will receive study drug, tests, and procedures that are for study-related purposes only, at no cost to you or your insurance company.
- You and your insurance company will continue to pay for your routine tests and services that would be performed as part of your regular health care.
Do I need permission from my doctor to participate in the LIBERTY 2 research study?
- No, your doctor does not need to give you permission to participate in the LIBERTY 2 research study. You may want to consult your doctor prior to participating in the study and keep your doctor informed about your progress.
Study Location
Red Rocks Ob/Gyn
Gwang-Yi Hwang, MD
255 Union Boulevard, Suite 235
Lakewood, CO 80228
(303) 985-9100
inquiry@proslc.com
About PRO
Physicians’ Research Options (PRO) is an experienced Clinical Research Company dedicated to the performance of Phase II, III and IV Pharmaceutical and Pilot/Pivotal Medical Device clinical trials. Our staff experience totals over 60 years in Clinical / Medical Research.
Our staff recruits for and manages studies in Utah, Nevada, and Colorado.
